RIV Capital Inc.
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- David E. Vautrin
- Full Time Employees
- 94
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Address
- 40 King Street West Toronto ON Canada M5H 3Y2
- IPO Date
- Sep 20, 2018
- Website
- rivcapital.com
- Similar Companies
- Business
- RIV Capital Inc. is a Canadian-based acquisition and investment company focused on the United States cannabis market through acquiring, investing in, and developing cannabis operators and brands to build a leading multistate platform. The company offers a diverse portfolio including brands and operators involved in cultivation, processing, retail, and wholesale distribution of cannabis products. Its product lines include cannabis edibles, beverages, inhalables, cosmetics, cannabis consumption accessories, pet products, and topicals, as well as investments in plant and food sciences, pharmaceuticals, biotechnology, and cannabis-related software and hardware. RIV Capital operates strategically in key U.S. markets such as New York, Florida, Texas, and Pennsylvania, managing cultivation facilities, processing plants, and retail dispensaries under its Etain brand. Founded and headquartered in Canada, RIV Capital has recently undergone a major change, completing its acquisition by Cansortium Inc. (operating under the FLUENT brand) in December 2024. This transaction, structured as a court-approved plan of arrangement, enhanced FLUENT's retail footprint to 42 dispensaries, added wholesale operations, and expanded its house of brands while eliminating around US$160 million of RIV Capital's debt. The merger created a vertically integrated cannabis operator with a robust footprint across four large U.S. states, leveraging synergies between the companies and positioning the combined entity for accelerated growth and profitability. This acquisition also led to the delisting of RIV Capital shares from the Canadian Securities Exchange, with integration efforts underway to drive operational efficiencies and market expansion. RIV Capital serves various segments within the cannabis sector—cultivation, processing, retail, wholesale, and consumer products—and targets licensed retailers, pharmacies, online consumer marketplaces, and delivery services across its geographic focus in North America. The company maintains oversight of subsidiaries including RIV Capital US Corporation and Etain LLC, providing financial control and operational management. Its strategic approach emphasizes growth through partnerships, investments in innovative cannabis technologies, and scaling brands for broader market penetration in the United States. This recent acquisition and operational consolidation mark a significant strategic shift toward becoming a leading multistate cannabis operator with an integrated supply chain and diversified product offering.
CSE Bulletin: Delist - RIV Capital Inc. (RIV)
RIV Capital Reports Financial Results for the Third Quarter Ended September 30, 2024
RIV Capital Provides Update on Revenue Performance and Synergy Realization Ahead of Anticipated Business Combination
RIV Capital Establishes Distribution Partnership with Nabis
RIV Capital and Cansortium Receive New York State Cannabis Control Board Approval for Change of Control
RIV Capital and Etain Commence Adult-Use Sales at Kingston Dispensary
RIV Capital and Cansortium Celebrate the Successful Launch of MOODS in New York
RIV Capital Appoints David E Vautrin to Interim CEO
RIV Capital and Etain Open Second Adult-Use Location in New York
RIV Capital's revenue more than doubles as New York cannabis market gears up
RIV Capital Reports Financial Results for the Second Quarter Ended June 30, 2024
RIV Capital Announces Shareholder Approval of Business Combination with Cansortium and Cansortium Announces Shareholder Approval of the Amendment Proposal
RIV Capital sets date for financial results for second quarter ended June 30, 2024
RIV Capital and Cansortium Inc. Provide Integration Update Ahead of Completing Merger
RIV Capital Strengthens Senior Leadership Team Ahead of Anticipated Transformational Merger with Cansortium Inc.
RIV Capital Reports Financial Results for the First Quarter Ended March 31, 2024
RIV Capital Applauds Reports that DEA Plans to Reschedule Cannabis
RIV Capital Inc. (CNPOF) Q4 2024 Earnings Call Transcript
RIV Capital Reports Financial Results for the Fiscal Quarter and Nine-Month Transition Period Ended December 31, 2023
RIV Capital Sets Date for Financial Results for the Fiscal Quarter and Nine-Month Transition Year Ended December 31, 2023